- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 14/485 - Epidermal growth factor [EGF], i.e. urogastrone
Patent holdings for IPC class C07K 14/485
Total number of patents in this class: 327
10-year publication summary
|
27
|
22
|
24
|
36
|
29
|
33
|
25
|
21
|
16
|
5
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Modernatx, Inc. | 1256 |
28 |
| Silver Creek Pharmaceuticals, Inc. | 29 |
9 |
| In3bio Ltd. | 23 |
8 |
| Gladiator Biosciences, Inc. | 14 |
7 |
| The Regents of the University of California | 19868 |
6 |
| NEXGEN Biotechnologies, Inc. | 48 |
6 |
| Zymeworks Inc. | 256 |
6 |
| Nexel Co., Ltd. | 26 |
6 |
| Affibody AB | 114 |
5 |
| IGF Oncology, LLC | 16 |
5 |
| Immunwork Inc. | 25 |
5 |
| Sun Kyo Lee | 18 |
5 |
| JCR Pharmaceuticals Co., Ltd. | 223 |
4 |
| Mind-NRG SARL | 4 |
4 |
| Regents of the University of Minnesota | 2688 |
4 |
| Novo Nordisk A/S | 2284 |
4 |
| Shanghai Synvida Biotechnology Co. Ltd. | 16 |
4 |
| The Board of Trustees of the Leland Stanford Junior University | 6402 |
3 |
| Board of Regents, The University of Texas System | 5772 |
3 |
| President and Fellows of Harvard College | 5966 |
3 |
| Other owners | 202 |